TY - JOUR AU - Rigas, R. PY - 2004 DA - 2004// TI - J. Taxane-platinum combinations in advanced non-small cell lung Cancer:a review JO - Oncologist VL - 9 UR - https://doi.org/10.1634/theoncologist.9-suppl_2-16 DO - 10.1634/theoncologist.9-suppl_2-16 ID - Rigas2004 ER - TY - JOUR AU - Kubota, K. AU - Sakai, H. AU - Katakami, N. AU - Nishio, M. AU - Inoue, A. AU - Okamoto, H. AU - Isobe, H. AU - Kunitoh, H. AU - Takiguchi, Y. AU - Kobayashi, K. PY - 2015 DA - 2015// TI - A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv190 DO - 10.1093/annonc/mdv190 ID - Kubota2015 ER - TY - JOUR AU - Hodge, J. W. AU - Garnett, C. T. AU - Farsaci, B. AU - Palena, C. AU - Tsang, K. Y. AU - Ferrone, S. AU - Gameiro, S. R. PY - 2013 DA - 2013// TI - Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death JO - Int J Cancer VL - 133 UR - https://doi.org/10.1002/ijc.28070 DO - 10.1002/ijc.28070 ID - Hodge2013 ER - TY - JOUR AU - Durm, G. AU - Hanna, N. PY - 2017 DA - 2017// TI - Second-line chemotherapy and beyond for non-small cell lung Cancer JO - Hematol Oncol Clin North Am VL - 31 UR - https://doi.org/10.1016/j.hoc.2016.08.002 DO - 10.1016/j.hoc.2016.08.002 ID - Durm2017 ER - TY - JOUR AU - Shukuya, T. AU - Ko, R. AU - Mori, K. AU - Kato, M. AU - Yagishita, S. AU - Kanemaru, R. AU - Honma, Y. AU - Shibayama, R. AU - Koyama, R. AU - Shimada, N. PY - 2015 DA - 2015// TI - Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents JO - Cancer Chemother Pharmacol VL - 76 UR - https://doi.org/10.1007/s00280-015-2843-3 DO - 10.1007/s00280-015-2843-3 ID - Shukuya2015 ER - TY - JOUR AU - Li, J. Y. AU - Duan, X. F. AU - Wang, L. P. AU - Xu, Y. J. AU - Huang, L. AU - Zhang, T. F. AU - Liu, J. Y. AU - Li, F. AU - Zhang, Z. AU - Yue, D. L. PY - 2014 DA - 2014// TI - Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer JO - J Immunol Res VL - 2014 ID - Li2014 ER - TY - JOUR AU - Li, J. AU - Wang, L. AU - Chen, X. AU - Li, L. AU - Li, Y. AU - Ping, Y. AU - Huang, L. AU - Yue, D. AU - Zhang, Z. AU - Wang, F. PY - 2017 DA - 2017// TI - CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-beta-mTOR-HIF-1 signaling in patients with non-small cell lung cancer JO - Oncoimmunology VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1320011 DO - 10.1080/2162402X.2017.1320011 ID - Li2017 ER - TY - JOUR AU - Garnett, C. T. AU - Schlom, J. AU - Hodge, J. W. PY - 2008 DA - 2008// TI - Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4025 DO - 10.1158/1078-0432.CCR-07-4025 ID - Garnett2008 ER - TY - JOUR AU - Fucikova, J. AU - Becht, E. AU - Iribarren, K. AU - Goc, J. AU - Remark, R. AU - Damotte, D. AU - Alifano, M. AU - Devi, P. AU - Biton, J. AU - Germain, C. PY - 2016 DA - 2016// TI - Calreticulin expression in human non-small cell lung cancers correlates with increased accumulation of antitumor immune cells and favorable prognosis JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-1142 DO - 10.1158/0008-5472.CAN-15-1142 ID - Fucikova2016 ER - TY - JOUR AU - Naoki Horikawa, K. A. AU - Matsumura, N. AU - Hamanishi, J. AU - Baba, T. AU - Yamaguchi, K. AU - Yoshioka, Y. AU - Koshiyama, M. AU - Konishi, I. PY - 2017 DA - 2017// TI - Expression of vascular endothelial growth factor in ovarian Cancer inhibits tumor immunity through the accumulation of myeloid-derived suppressor cells JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-0387 DO - 10.1158/1078-0432.CCR-16-0387 ID - Naoki Horikawa2017 ER - TY - JOUR AU - Kang, R. AU - Zhang, Q. AU - Zeh, H. J. AU - Lotze, M. T. AU - Tang, D. PY - 2013 DA - 2013// TI - HMGB1 in cancer: good, bad, or both? JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-13-0495 DO - 10.1158/1078-0432.CCR-13-0495 ID - Kang2013 ER - TY - JOUR AU - Messmer, D. AU - Yang, H. AU - Telusma, G. AU - Knoll, F. AU - Li, J. AU - Messmer, B. AU - Tracey, K. J. AU - Chiorazzi, N. PY - 2004 DA - 2004// TI - High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization JO - J Immunol VL - 173 UR - https://doi.org/10.4049/jimmunol.173.1.307 DO - 10.4049/jimmunol.173.1.307 ID - Messmer2004 ER - TY - JOUR AU - Dumitriu, I. E. AU - Bianchi, M. E. AU - Bacci, M. AU - Manfredi, A. A. AU - Rovere-Querini, P. PY - 2006 DA - 2006// TI - The secretion of HMGB1 is required for the migration of maturing dendritic cells JO - J Leukoc Biol VL - 81 UR - https://doi.org/10.1189/jlb.0306171 DO - 10.1189/jlb.0306171 ID - Dumitriu2006 ER - TY - JOUR AU - Ivanov, S. AU - Dragoi, A. M. AU - Wang, X. AU - Dallacosta, C. AU - Louten, J. AU - Musco, G. AU - Sitia, G. AU - Yap, G. S. AU - Wan, Y. AU - Biron, C. A. PY - 2007 DA - 2007// TI - A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2006-09-044776 DO - 10.1182/blood-2006-09-044776 ID - Ivanov2007 ER - TY - JOUR AU - He, Y. AU - Zha, J. AU - Wang, Y. AU - Liu, W. AU - Yang, X. AU - Yu, P. PY - 2013 DA - 2013// TI - Tissue damage-associated “danger signals” influence T-cell responses that promote the progression of preneoplasia to cancer JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-2704 DO - 10.1158/0008-5472.CAN-12-2704 ID - He2013 ER - TY - JOUR AU - Patnaik, A. AU - Swanson, K. D. AU - Csizmadia, E. AU - Solanki, A. AU - Landon-Brace, N. AU - Gehring, M. P. AU - Helenius, K. AU - Olson, B. M. AU - Pyzer, A. R. AU - Wang, L. C. PY - 2017 DA - 2017// TI - Cabozantinib eradicates advanced murine prostate Cancer by activating antitumor innate immunity JO - Cancer Discov VL - 7 UR - https://doi.org/10.1158/2159-8290.CD-16-0778 DO - 10.1158/2159-8290.CD-16-0778 ID - Patnaik2017 ER - TY - JOUR AU - Campana, L. AU - Bosurgi, L. AU - Bianchi, M. E. AU - Manfredi, A. A. AU - Rovere-Querini, P. PY - 2009 DA - 2009// TI - Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells JO - J Leukoc Biol VL - 86 UR - https://doi.org/10.1189/jlb.0908576 DO - 10.1189/jlb.0908576 ID - Campana2009 ER - TY - JOUR AU - Sims, G. P. AU - Rowe, D. C. AU - Rietdijk, S. T. AU - Herbst, R. AU - Coyle, A. J. PY - 2010 DA - 2010// TI - HMGB1 and RAGE in inflammation and cancer JO - Annu Rev Immunol VL - 28 UR - https://doi.org/10.1146/annurev.immunol.021908.132603 DO - 10.1146/annurev.immunol.021908.132603 ID - Sims2010 ER - TY - JOUR AU - Kew, R. R. AU - Penzo, M. AU - Habiel, D. M. AU - Marcu, K. B. PY - 2012 DA - 2012// TI - The IKKalpha-dependent NF-kappaB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1 JO - J Immunol VL - 188 UR - https://doi.org/10.4049/jimmunol.1102454 DO - 10.4049/jimmunol.1102454 ID - Kew2012 ER - TY - JOUR AU - Bertheloot, D. AU - Latz, E. PY - 2017 DA - 2017// TI - HMGB1, IL-1alpha, IL-33 and S100 proteins: dual-function alarmins JO - Cell Mol Immunol VL - 14 UR - https://doi.org/10.1038/cmi.2016.34 DO - 10.1038/cmi.2016.34 ID - Bertheloot2017 ER - TY - JOUR AU - Liu, J. Y. AU - Li, F. AU - Wang, L. P. AU - Chen, X. F. AU - Wang, D. AU - Cao, L. AU - Ping, Y. AU - Zhao, S. AU - Li, B. AU - Thorne, S. H. PY - 2015 DA - 2015// TI - CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma JO - Br J Cancer VL - 113 UR - https://doi.org/10.1038/bjc.2015.290 DO - 10.1038/bjc.2015.290 ID - Liu2015 ER - TY - JOUR AU - Fang, W. B. AU - Mafuvadze, B. AU - Yao, M. AU - Zou, A. AU - Portsche, M. AU - Cheng, N. PY - 2015 DA - 2015// TI - TGF-beta negatively regulates CXCL1 chemokine expression in mammary fibroblasts through enhancement of Smad2/3 and suppression of HGF/c-met signaling mechanisms JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0135063 DO - 10.1371/journal.pone.0135063 ID - Fang2015 ER - TY - JOUR AU - Al-Khayal, K. AU - Alafeefy, A. AU - Vaali-Mohammed, M. A. AU - Mahmood, A. AU - Zubaidi, A. AU - Al-Obeed, O. AU - Khan, Z. AU - Abdulla, M. AU - Ahmad, R. PY - 2017 DA - 2017// TI - Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-016-3005-7 DO - 10.1186/s12885-016-3005-7 ID - Al-Khayal2017 ER - TY - JOUR AU - Darcy, P. K. AU - Haynes, N. M. AU - Snook, M. B. AU - Trapani, J. A. AU - Cerruti, L. AU - Jane, S. M. AU - Smyth, M. J. PY - 2000 DA - 2000// TI - Redirected perforin-dependent lysis of Colon carcinoma by ex vivo genetically engineered CTL JO - J Immunol VL - 164 UR - https://doi.org/10.4049/jimmunol.164.7.3705 DO - 10.4049/jimmunol.164.7.3705 ID - Darcy2000 ER - TY - JOUR AU - Wang, L. X. AU - Westwood, J. A. AU - Moeller, M. AU - Duong, C. P. AU - Wei, W. Z. AU - Malaterre, J. AU - Trapani, J. A. AU - Neeson, P. AU - Smyth, M. J. AU - Kershaw, M. H. PY - 2010 DA - 2010// TI - Tumor ablation by gene-modified T cells in the absence of autoimmunity JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-2884 DO - 10.1158/0008-5472.CAN-10-2884 ID - Wang2010 ER - TY - JOUR AU - Haynes, N. M. AU - Trapani, J. A. AU - Teng, M. W. AU - Jackson, J. T. AU - Cerruti, L. AU - Jane, S. M. AU - Kershaw, M. H. AU - Smyth, M. J. AU - Darcy, P. K. PY - 2002 DA - 2002// TI - Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors JO - Blood VL - 100 UR - https://doi.org/10.1182/blood-2002-04-1041 DO - 10.1182/blood-2002-04-1041 ID - Haynes2002 ER - TY - JOUR AU - Zhang, Z. AU - Zhao, X. AU - Zhang, T. AU - Wang, L. AU - Yang, L. AU - Huang, L. AU - Li, F. AU - Liu, J. AU - Yue, D. AU - Wang, F. PY - 2015 DA - 2015// TI - Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood JO - Cytotherapy VL - 17 UR - https://doi.org/10.1016/j.jcyt.2014.09.006 DO - 10.1016/j.jcyt.2014.09.006 ID - Zhang2015 ER - TY - JOUR AU - Spaks, A. PY - 2017 DA - 2017// TI - Role of CXC group chemokines in lung cancer development and progression JO - J Thorac Dis VL - 9 UR - https://doi.org/10.21037/jtd.2017.03.61 DO - 10.21037/jtd.2017.03.61 ID - Spaks2017 ER - TY - JOUR AU - Liu, Z. AU - Ravindranathan, R. AU - Li, J. AU - Kalinski, P. AU - Guo, Z. S. AU - Bartlett, D. L. PY - 2016 DA - 2016// TI - CXCL11-armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2015.1091554 DO - 10.1080/2162402X.2015.1091554 ID - Liu2016 ER - TY - JOUR AU - Proost, P. AU - Fenwick, P. S. AU - Macedo, P. AU - Kilty, I. C. AU - Barnes, P. J. AU - Donnelly, L. E. PY - 2015 DA - 2015// TI - Effect of JAK inhibitors on release of CXCL9, CXCL10 and CXCL11 from human airway epithelial cells JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0128757 DO - 10.1371/journal.pone.0128757 ID - Proost2015 ER - TY - JOUR AU - Meares, G. P. AU - Ma, X. AU - Qin, H. AU - Benveniste, E. N. PY - 2012 DA - 2012// TI - Regulation of CCL20 expression in astrocytes by IL-6 and IL-17 JO - Glia VL - 60 UR - https://doi.org/10.1002/glia.22307 DO - 10.1002/glia.22307 ID - Meares2012 ER - TY - JOUR AU - Hosokawa, Y. AU - Shindo, S. AU - Hosokawa, I. AU - Ozaki, K. AU - Matsuo, T. PY - 2014 DA - 2014// TI - IL-6 trans-signaling enhances CCL20 production from IL-1beta-stimulated human periodontal ligament cells JO - Inflammation VL - 37 UR - https://doi.org/10.1007/s10753-013-9750-8 DO - 10.1007/s10753-013-9750-8 ID - Hosokawa2014 ER - TY - JOUR AU - Min, H. J. AU - Kim, J. H. AU - Yoo, J. E. AU - Oh, J. H. AU - Kim, K. S. AU - Yoon, J. H. AU - Kim, C. H. PY - 2017 DA - 2017// TI - ROS-dependent HMGB1 secretion upregulates IL-8 in upper airway epithelial cells under hypoxic condition JO - Mucosal Immunol VL - 10 UR - https://doi.org/10.1038/mi.2016.82 DO - 10.1038/mi.2016.82 ID - Min2017 ER - TY - JOUR AU - Mitchell, D. AU - Olive, C. PY - 2010 DA - 2010// TI - Regulation of toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases JO - Mol Immunol VL - 47 UR - https://doi.org/10.1016/j.molimm.2010.04.004 DO - 10.1016/j.molimm.2010.04.004 ID - Mitchell2010 ER - TY - JOUR AU - Namkoong, H. AU - Song, M. Y. AU - Seo, Y. B. AU - Choi, D. H. AU - Kim, S. W. AU - Im, S. J. AU - Sung, Y. C. AU - Park, Y. PY - 2014 DA - 2014// TI - Enhancement of antigen-specific CD8 T cell responses by co-delivery of fc-fused CXCL11 JO - Vaccine VL - 32 UR - https://doi.org/10.1016/j.vaccine.2013.07.066 DO - 10.1016/j.vaccine.2013.07.066 ID - Namkoong2014 ER - TY - JOUR AU - Rosenblum, J. M. AU - Shimoda, N. AU - Schenk, A. D. AU - Zhang, H. AU - Kish, D. D. AU - Keslar, K. AU - Farber, J. M. AU - Fairchild, R. L. PY - 2010 DA - 2010// TI - CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors JO - J Immunol VL - 184 UR - https://doi.org/10.4049/jimmunol.0903831 DO - 10.4049/jimmunol.0903831 ID - Rosenblum2010 ER - TY - JOUR AU - Yoon, H. A. AU - Eo, S. K. PY - 2007 DA - 2007// TI - Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus JO - Immunology VL - 120 UR - https://doi.org/10.1111/j.1365-2567.2006.02490.x DO - 10.1111/j.1365-2567.2006.02490.x ID - Yoon2007 ER - TY - JOUR AU - Liu, W. AU - Zhang, Z. AU - Zhang, Y. AU - Chen, X. AU - Guo, S. AU - Lei, Y. AU - Xu, Y. AU - Ji, C. AU - Bi, Z. AU - Wang, K. PY - 2015 DA - 2015// TI - HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway JO - Cancer Biol Ther VL - 16 UR - https://doi.org/10.1080/15384047.2015.1017691 DO - 10.1080/15384047.2015.1017691 ID - Liu2015 ER - TY - JOUR AU - Pan, B. AU - Chen, D. AU - Huang, J. AU - Wang, R. AU - Feng, B. AU - Song, H. AU - Chen, L. PY - 2014 DA - 2014// TI - HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-165 DO - 10.1186/1476-4598-13-165 ID - Pan2014 ER - TY - JOUR AU - Arnold, T. AU - Michlmayr, A. AU - Baumann, S. AU - Burghuber, C. AU - Pluschnig, U. AU - Bartsch, R. AU - Steger, G. AU - Gnant, M. AU - Bergmann, M. AU - Bachleitner-Hofmann, T. PY - 2013 DA - 2013// TI - Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer JO - Eur J Clin Investig VL - 43 UR - https://doi.org/10.1111/eci.12043 DO - 10.1111/eci.12043 ID - Arnold2013 ER - TY - JOUR AU - Buoncervello, M. AU - Borghi, P. AU - Romagnoli, G. AU - Spadaro, F. AU - Belardelli, F. AU - Toschi, E. AU - Gabriele, L. PY - 2012 DA - 2012// TI - Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast Cancer cells JO - Neoplasia VL - 14 UR - https://doi.org/10.1593/neo.121020 DO - 10.1593/neo.121020 ID - Buoncervello2012 ER - TY - JOUR AU - Lee, H. J. AU - Kim, A. AU - Song, I. H. AU - Park, I. A. AU - Yu, J. H. AU - Ahn, J. H. AU - Gong, G. PY - 2016 DA - 2016// TI - Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer JO - Pathol Int VL - 66 UR - https://doi.org/10.1111/pin.12393 DO - 10.1111/pin.12393 ID - Lee2016 ER - TY - JOUR AU - Kanegasaki, S. AU - Matsushima, K. AU - Shiraishi, K. AU - Nakagawa, K. AU - Tsuchiya, T. PY - 2014 DA - 2014// TI - Macrophage inflammatory protein derivative ECI301 enhances the alarmin-associated abscopal benefits of tumor radiotherapy JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-0551 DO - 10.1158/0008-5472.CAN-14-0551 ID - Kanegasaki2014 ER - TY - STD TI - Kang R, Xie Y, Zhang Q, Hou W, Jiang Q, Zhu S, Liu J, Zeng D, Wang H, Bartlett DL, et al. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer. Cell Res. 2017;27:916–32. ID - ref44 ER - TY - JOUR AU - Exner, R. AU - Sachet, M. AU - Arnold, T. AU - Zinn-Zinnenburg, M. AU - Michlmayr, A. AU - Dubsky, P. AU - Bartsch, R. AU - Steger, G. AU - Gnant, M. AU - Bergmann, M. PY - 2016 DA - 2016// TI - Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy JO - Cancer Med VL - 5 UR - https://doi.org/10.1002/cam4.827 DO - 10.1002/cam4.827 ID - Exner2016 ER - TY - JOUR AU - Chuangui, C. AU - Peng, T. AU - Zhentao, Y. PY - 2012 DA - 2012// TI - The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma JO - Pathol Oncol Res VL - 18 UR - https://doi.org/10.1007/s12253-012-9539-3 DO - 10.1007/s12253-012-9539-3 ID - Chuangui2012 ER -